Pediatric impetigo: an expert panel opinion about its main controversies

J Chemother. 2022 Sep;34(5):279-285. doi: 10.1080/1120009X.2021.1961185. Epub 2021 Aug 18.

Abstract

Bacterial impetigo is one of the most common skin infection in childhood. Uncertainty exists about its management. This article offers practical suggestions, given the existing evidence and experts' opinions, for correctly managing pediatric impetigo in both hospital and ambulatory settings. Italian physicians with an expertise on pediatric impetigo appointed a working group. A preliminary literature search using Pubmed/MEDLINE and Cochrane Library databases has been performed. The most common controversial issues about pediatric impetigo have been identified and then discussed from multidisciplinary perspectives, according to the 'structured controversy' methodology, a technique discovered and designed to get engaged in a controversy and then guide participants to seek consensus. The expert panels identified 10 main controversies about pediatric impetigo. All of them have been discussed from dermatological, pediatric, pharmacological and microbiological points of view reaching consensus. Each controversy has been revised thus giving practical issues for an easy use in clinical practice. Based on clinical experts' opinion, local epidemiology and literature review this article offers practical suggestions for the management of pediatric impetigo trying to reduce uncertainty in this setting of care.

Keywords: Pediatric skin infections; antibiotic resistance; children; impetigo; ozenoxacin.

Publication types

  • Review

MeSH terms

  • Aminopyridines / pharmacology
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Cellulitis / drug therapy
  • Child
  • Humans
  • Impetigo* / diagnosis
  • Impetigo* / drug therapy
  • Quinolones* / pharmacology

Substances

  • Aminopyridines
  • Anti-Bacterial Agents
  • Quinolones